{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:27:32Z","timestamp":1782937652159,"version":"3.54.5"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R35NS097273 U54NS123743 P01NS084974 RF1NS120992 1U19AG063911"],"award-info":[{"award-number":["R35NS097273 U54NS123743 P01NS084974 RF1NS120992 1U19AG063911"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016295","name":"Sol Goldman Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019309","name":"Albertson Parkinson\u2019s Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019309","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1U19AG063911"],"award-info":[{"award-number":["1U19AG063911"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Spinocerebellar ataxia type 3 (SCA3) is a dominantly inherited cerebellar ataxia caused by the expansion of a polyglutamine (polyQ) repeat in the gene encoding ATXN3. The polyQ expansion induces protein inclusion formation in the neurons of patients and results in neuronal degeneration in the cerebellum and other brain regions. We used adeno-associated virus (AAV) technology to develop a new mouse model of SCA3 that recapitulates several features of the human disease, including locomotor defects, cerebellar-specific neuronal loss, polyQ-expanded ATXN3 inclusions, and TDP-43 pathology. We also found that neurofilament light is elevated in the cerebrospinal fluid (CSF) of the SCA3 animals, and the expanded polyQ-ATXN3 protein can be detected in the plasma. Interestingly, the levels of polyQ-ATXN3 in plasma correlated with measures of cerebellar degeneration and locomotor deficits in 6-month-old SCA3 mice, supporting the hypothesis that this factor could act as a biomarker for SCA3.<\/jats:p>","DOI":"10.3389\/fcell.2022.863089","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T05:53:05Z","timestamp":1647841985000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Plasma PolyQ-ATXN3 Levels Associate With Cerebellar Degeneration and Behavioral Abnormalities in a New AAV-Based SCA3 Mouse Model"],"prefix":"10.3389","volume":"10","author":[{"given":"Karen","family":"Jansen-West","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany W.","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian M.","family":"Daughrity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yari","family":"Carlomagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Del Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishe","family":"Kurti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Y.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Dunmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Castanedes-Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew K.","family":"Wszolek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Fryer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Petrucelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Prudencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e3341","DOI":"10.1371\/journal.pone.0003341","article-title":"Allele-specific RNA Silencing of Mutant Ataxin-3 Mediates Neuroprotection in a Rat Model of Machado-Joseph Disease","volume":"3","author":"Alves","year":"2008","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1093\/hmg\/ddq111","article-title":"Silencing Ataxin-3 Mitigates Degeneration in a Rat Model of Machado-Joseph Disease: No Role for Wild-type Ataxin-3?","volume":"19","author":"Alves","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"7418","DOI":"10.1523\/JNEUROSCI.4540-06.2007","article-title":"Nuclear Localization of Ataxin-3 Is Required for the Manifestation of Symptoms in SCA3: In Vivo Evidence","volume":"27","author":"Bichelmeier","year":"2007","journal-title":"J. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.nbd.2009.08.002","article-title":"A Transgenic Mouse Model of Spinocerebellar Ataxia Type 3 Resembling Late Disease Onset and Gender-specific Instability of CAG Repeats","volume":"37","author":"Boy","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1093\/hmg\/ddp381","article-title":"Reversibility of Symptoms in a Conditional Mouse Model of Spinocerebellar Ataxia Type 3","volume":"18","author":"Boy","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1093\/hmg\/ddg344","article-title":"The Polyglutamine Neurodegenerative Protein Ataxin-3 Binds Polyubiquitylated Proteins and Has Ubiquitin Protease Activity","volume":"12","author":"Burnett","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12311-020-01179-7","article-title":"Antisense Oligonucleotide Therapy Targeted against ATXN3 Improves Potassium Channel-Mediated Purkinje Neuron Dysfunction in Spinocerebellar Ataxia Type 3","volume":"20","author":"Bushart","year":"2021","journal-title":"Cerebellum"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/hmg\/11.9.1075","article-title":"YAC Transgenic Mice Carrying Pathological Alleles of the MJD1 Locus Exhibit a Mild and Slowly Progressive Cerebellar Deficit","volume":"11","author":"Cemal","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1523\/jneurosci.19-23-10338.1999","article-title":"Analysis of the Role of Heat Shock Protein (Hsp) Molecular Chaperones in Polyglutamine Disease","volume":"19","author":"Chai","year":"1999","journal-title":"J. Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e67680","DOI":"10.1371\/journal.pone.0067680","article-title":"Capsid Serotype and Timing of Injection Determines AAV Transduction in the Neonatal Mice Brain","volume":"8","author":"Chakrabarty","year":"2013","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13024-019-0310-z","article-title":"Aberrant Deposition of Stress Granule-Resident Proteins Linked to C9orf72-Associated TDP-43 Proteinopathy","volume":"14","author":"Chew","year":"2019","journal-title":"Mol. Neurodegeneration"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1126\/science.aaa9344","article-title":"C9ORF72 Repeat Expansions in Mice Cause TDP-43 Pathology, Neuronal Loss, and Behavioral Deficits","volume":"348","author":"Chew","year":"2015","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.nbd.2008.03.011","article-title":"Polyglutamine-expanded Ataxin-3 Causes Cerebellar Dysfunction of SCA3 Transgenic Mice by Inducing Transcriptional Dysregulation","volume":"31","author":"Chou","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"6198","DOI":"10.1093\/hmg\/ddv336","article-title":"Tau Deposition Drives Neuropathological, Inflammatory and Behavioral Abnormalities Independently of Neuronal Loss in a Novel Mouse Model","volume":"24","author":"Cook","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/mds.28140","article-title":"In Vivo Molecular Signatures of Cerebellar Pathology in Spinocerebellar Ataxia Type 3","volume":"35","author":"Costa","year":"2020","journal-title":"Mov Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"11445","DOI":"10.1038\/ncomms11445","article-title":"Caloric Restriction Blocks Neuropathology and Motor Deficits in Machado-Joseph Disease Mouse Models through SIRT1 Pathway","volume":"7","author":"Cunha-Santos","year":"2016","journal-title":"Nat. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ana.410390411","article-title":"Spinocerebellar Ataxia 3 and Machado-Joseph Disease: Clinical, Molecular, and Neuropathological Features","volume":"39","author":"Durr","year":"1996","journal-title":"Ann. Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e24308","DOI":"10.1371\/journal.pone.0024308","article-title":"Targeting Several CAG Expansion Diseases by a Single Antisense Oligonucleotide","volume":"6","author":"Evers","year":"2011","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.nbd.2013.04.019","article-title":"Ataxin-3 Protein Modification as a Treatment Strategy for Spinocerebellar Ataxia Type 3: Removal of the CAG Containing Exon","volume":"58","author":"Evers","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/jnen\/62.10.1006","article-title":"Gene Expression Profiling in Ataxin-3 Expressing Cell Lines Reveals Distinct Effects of normal and Mutant Ataxin-3","volume":"62","author":"Evert","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"26304","DOI":"10.1074\/jbc.M110.125039","article-title":"Interaction with Polyglutamine Aggregates Reveals a Q\/N-rich Domain in TDP-43","volume":"285","author":"Fuentealba","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e75091","DOI":"10.1371\/journal.pone.0075091","article-title":"Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases","volume":"8","author":"Gaiottino","year":"2013","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/ana.23866","article-title":"Caffeine and Adenosine A2Areceptor Inactivation Decrease Striatal Neuropathology in a Lentiviral-Based Model of Machado-Joseph Disease","volume":"73","author":"Gon\u00e7alves","year":"2013","journal-title":"Ann. Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"10266","DOI":"10.1523\/JNEUROSCI.2734-04.2004","article-title":"A Mutant Ataxin-3 Putative-Cleavage Fragment in Brains of Machado-Joseph Disease Patients and Transgenic Mice Is Cytotoxic above a Critical Concentration","volume":"24","author":"Goti","year":"2004","journal-title":"J. Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.3791\/1787","article-title":"A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia","volume":"39","author":"Guyenet","year":"2010","journal-title":"JoVE"},{"key":"B26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12035-021-02610-8","article-title":"A Novel SCA3 Knock-In Mouse Model Mimics the Human SCA3 Disease Phenotype Including Neuropathological, Behavioral, and Transcriptional Abnormalities Especially in Oligodendrocytes","volume":"59","author":"Haas","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1002\/mds.28749","article-title":"Polyglutamine\u2010Expanded Ataxin\u20103: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood","volume":"36","author":"H\u00fcbener\u2010Schmid","year":"2021","journal-title":"Move. Disord."},{"key":"B28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/ng0696-196","article-title":"Expanded Polyglutamine in the Machado-Joseph Disease Protein Induces Cell Death In Vitro and In Vivo","volume":"13","author":"Ikeda","year":"1996","journal-title":"Nat. Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1111\/bph.14637","article-title":"Adeno\u2010associated Virus\u2010based Alzheimer's Disease Mouse Models and Potential New Therapeutic Avenues","volume":"176","author":"Ittner","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.parkreldis.2021.07.018","article-title":"Urine Levels of the Polyglutamine Ataxin-3 Protein Are Elevated in Patients with Spinocerebellar Ataxia Type 3","volume":"89","author":"Koike","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"45004","DOI":"10.1074\/jbc.M205259200","article-title":"Ataxin-3 Is a Histone-Binding Protein with Two Independent Transcriptional Corepressor Activities","volume":"277","author":"Li","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13024-019-0338-0","article-title":"Neurofilament Light Chain Is a Promising Serum Biomarker in Spinocerebellar Ataxia Type 3","volume":"14","author":"Li","year":"2019","journal-title":"Mol. Neurodegeneration"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1007\/s00415-013-6998-8","article-title":"Widespread Neuronal Damage and Cognitive Dysfunction in Spinocerebellar Ataxia Type 3","volume":"260","author":"Lopes","year":"2013","journal-title":"J. Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"104951","DOI":"10.1016\/j.nbd.2020.104951","article-title":"Use of Adeno-Associated Virus-Mediated Delivery of Mutant Huntingtin to Study the Spreading Capacity of the Protein in Mice and Non-human Primates","volume":"141","author":"Maxan","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ana.25264","article-title":"Oligonucleotide Therapy Mitigates Disease in Spinocerebellar Ataxia Type 3 Mice","volume":"84","author":"McLoughlin","year":"2018","journal-title":"Ann. Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"104635","DOI":"10.1016\/j.nbd.2019.104635","article-title":"Pathogenesis of SCA3 and Implications for Other Polyglutamine Diseases","volume":"134","author":"McLoughlin","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/nchembio.694","article-title":"Identifying Polyglutamine Protein Species In Situ that Best Predict Neurodegeneration","volume":"7","author":"Miller","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"7195","DOI":"10.1073\/pnas.1231012100","article-title":"Allele-specific Silencing of Dominant Disease Genes","volume":"100","author":"Miller","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.omtn.2017.04.005","article-title":"Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models","volume":"7","author":"Moore","year":"2017","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"B40","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/nan.12075","article-title":"FUS Colocalizes with Polyglutamine, but Not with TDP-43 in Neuronal Intranuclear Inclusions in Spinocerebellar Ataxia Type 2","volume":"40","author":"Mori","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2021.0020","article-title":"MiRNA-Mediated Knockdown of ATXN3 Alleviates Molecular Disease Hallmarks in a Mouse Model for Spinocerebellar Ataxia Type 3","author":"Nobre","year":"2021","journal-title":"Nucleic Acid Ther"},{"key":"B42","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12311-012-0432-0","article-title":"Overexpression of Mutant Ataxin-3 in Mouse Cerebellum Induces Ataxia and Cerebellar Neuropathology","volume":"12","author":"N\u00f3brega","year":"","journal-title":"Cerebellum"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e100086","DOI":"10.1371\/journal.pone.0100086","article-title":"RNA Interference Mitigates Motor and Neuropathological Deficits in a Cerebellar Mouse Model of Machado-Joseph Disease","volume":"9","author":"N\u00f3brega","year":"2014","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e52396","DOI":"10.1371\/journal.pone.0052396","article-title":"Silencing Mutant Ataxin-3 Rescues Motor Deficits and Neuropathology in Machado-Joseph Disease Transgenic Mice","volume":"8","author":"N\u00f3brega","year":"","journal-title":"PLoS One"},{"key":"B45","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.gde.2012.01.001","article-title":"Polyglutamine Neurodegeneration: Expanded Glutamines Enhance Native Functions","volume":"22","author":"Orr","year":"2012","journal-title":"Curr. Opin. Genet. Develop."},{"key":"B46","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1089\/scd.2017.0209","article-title":"CRISPR\/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells","volume":"27","author":"Ouyang","year":"2018","journal-title":"Stem Cell Develop."},{"key":"B47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/mds.28783","article-title":"Blood Neurofilament Light Chain in Genetic Ataxia: A Meta\u2010Analysis","volume":"37","author":"Peng","year":"2021","journal-title":"Move. Disord."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e2977","DOI":"10.1212\/WNL.0000000000010671","article-title":"Association of Serum Neurofilament Light and Disease Severity in Patients with Spinocerebellar Ataxia Type 3","volume":"95","author":"Peng","year":"2020","journal-title":"Neurology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"eabb7086","DOI":"10.1126\/scitranslmed.abb7086","article-title":"Toward Allele-specific Targeting Therapy and Pharmacodynamic Marker for Spinocerebellar Ataxia Type 3","volume":"12","author":"Prudencio","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/hmg\/ddu532","article-title":"A Knockin Mouse Model of Spinocerebellar Ataxia Type 3 Exhibits Prominent Aggregate Pathology and Aberrant Splicing of the Disease Gene Transcript","volume":"24","author":"Ramani","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1038\/mt.2013.152","article-title":"Silencing Mutant ATXN3 Expression Resolves Molecular Phenotypes in SCA3 Transgenic Mice","volume":"21","author":"Rodr\u00edguez-Lebr\u00f3n","year":"2013","journal-title":"Mol. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1212\/wnl.32.2.192","article-title":"Joseph Disease: a Multisystem Degenerative Disorder of the Nervous System","volume":"32","author":"Sachdev","year":"1982","journal-title":"Neurology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e140723","DOI":"10.1172\/JCI140723","article-title":"Huntington's Disease Mice and Human Brain Tissue Exhibit Increased G3BP1 Granules and TDP43 Mislocalization","volume":"131","author":"Sanchez","year":"2021","journal-title":"J. Clin. Invest."},{"key":"B54","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s12311-011-0340-8","article-title":"Pathoanatomy of Cerebellar Degeneration in Spinocerebellar Ataxia Type 2 (SCA2) and Type 3 (SCA3)","volume":"11","author":"Scherzed","year":"2012","journal-title":"Cerebellum"},{"key":"B55","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.bbrc.2007.08.062","article-title":"Inactivation of the Mouse Atxn3 (Ataxin-3) Gene Increases Protein Ubiquitination","volume":"362","author":"Schmitt","year":"2007","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","article-title":"Colocalization of Transactivation-Responsive DNA-Binding Protein 43 and Huntingtin in Inclusions of Huntington Disease","volume":"67","author":"Schwab","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00401-010-0717-7","article-title":"Axonal Inclusions in Spinocerebellar Ataxia Type 3","volume":"120","author":"Seidel","year":"2010","journal-title":"Acta Neuropathol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"13002","DOI":"10.1523\/JNEUROSCI.2789-11.2011","article-title":"Early Changes in Cerebellar Physiology Accompany Motor Dysfunction in the Polyglutamine Disease Spinocerebellar Ataxia Type 3","volume":"31","author":"Shakkottai","year":"2011","journal-title":"J. Neurosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/1352458518765666","article-title":"Serum Neurofilament Light Chain Is a Biomarker of Acute and Chronic Neuronal Damage in Early Multiple Sclerosis","volume":"25","author":"Siller","year":"2019","journal-title":"Mult. Scler."},{"key":"B60","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.nbd.2010.05.021","article-title":"Motor Uncoordination and Neuropathology in a Transgenic Mouse Model of Machado-Joseph Disease Lacking Intranuclear Inclusions and Ataxin-3 Cleavage Products","volume":"40","author":"Silva-Fernandes","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s13311-013-0255-9","article-title":"Chronic Treatment with 17-DMAG Improves Balance and Coordination in a New Mouse Model of Machado-Joseph Disease","volume":"11","author":"Silva-Fernandes","year":"2014","journal-title":"Neurotherapeutics"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1093\/brain\/aws177","article-title":"Calpastatin-mediated Inhibition of Calpains in the Mouse Brain Prevents Mutant Ataxin 3 Proteolysis, Nuclear Localization and Aggregation, Relieving Machado-Joseph Disease","volume":"135","author":"Simoes","year":"2012","journal-title":"Brain"},{"key":"B63","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/neup.12433","article-title":"Deregulation of Autophagy in Postmortem Brains of Machado-Joseph Disease Patients","volume":"38","author":"Sittler","year":"2018","journal-title":"Neuropathology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00401-017-1786-7","article-title":"Co-occurrence of Mixed Proteinopathies in Late-Stage Huntington's Disease","volume":"135","author":"St-Amour","year":"2018","journal-title":"Acta Neuropathol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.nbd.2014.09.020","article-title":"A New Humanized Ataxin-3 Knock-In Mouse Model Combines the Genetic Features, Pathogenesis of Neurons and Glia and Late Disease Onset of SCA3\/MJD","volume":"73","author":"Switonski","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1212\/wnl.44.7.1302","article-title":"A Clinical and Pathologic Study of a Large Japanese Family with Machado\u2010 Joseph Disease Tightly Linked to the DNA Markers on Chromosome 14q","volume":"44","author":"Takiyama","year":"1994","journal-title":"Neurology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00401-009-0552-x","article-title":"Selective Occurrence of TDP-43-Immunoreactive Inclusions in the Lower Motor Neurons in Machado-Joseph Disease","volume":"118","author":"Tan","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"107616","DOI":"10.1016\/j.celrep.2020.107616","article-title":"Hexanucleotide Repeat Expansions in c9FTD\/ALS and SCA36 Confer Selective Patterns of Neurodegeneration In Vivo","volume":"31","author":"Todd","year":"2020","journal-title":"Cel Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/embor.2008.31","article-title":"Lentivector\u2010mediated rescue from Cerebellar Ataxia in a Mouse Model of Spinocerebellar Ataxia","volume":"9","author":"Torashima","year":"2008","journal-title":"EMBO Rep."},{"key":"B70","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00401-011-0862-7","article-title":"Spinocerebellar Ataxia Type 2 (SCA2) Is Associated with TDP-43 Pathology","volume":"122","author":"Toyoshima","year":"2011","journal-title":"Acta Neuropathol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1074\/jbc.RA118.005801","article-title":"Physiological and Pathophysiological Characteristics of Ataxin-3 Isoforms","volume":"294","author":"Weish\u00e4upl","year":"2019","journal-title":"J. Biol. Chem."},{"key":"B72","doi-asserted-by":"publisher","first-page":"8168","DOI":"10.1007\/s12035-019-01643-4","article-title":"Altered Levels of Proteins and Phosphoproteins, in the Absence of Early Causative Transcriptional Changes, Shape the Molecular Pathogenesis in the Brain of Young Presymptomatic Ki91 SCA3\/MJD Mouse","volume":"56","author":"Wiatr","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e11803","DOI":"10.15252\/emmm.201911803","article-title":"Neurofilaments in Spinocerebellar Ataxia Type 3: Blood Biomarkers at the Preataxic and Ataxic Stage in Humans and Mice","volume":"12","author":"Wilke","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s004010000277","article-title":"Involvement of the Cerebral Cortex and Autonomic Ganglia in Machado-Joseph Disease","volume":"101","author":"Yamada","year":"2001","journal-title":"Acta Neuropathol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ana.410190207","article-title":"Joseph's Disease: Clinical and Pathological Studies in a Japanese Family","volume":"19","author":"Yuasa","year":"1986","journal-title":"Ann. Neurol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3389\/fncel.2018.00366","article-title":"Plasma Markers of Neurodegeneration Are Raised in Friedreich's Ataxia","volume":"12","author":"Zeitlberger","year":"2018","journal-title":"Front. Cel. Neurosci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"eaav2606","DOI":"10.1126\/science.aav2606","article-title":"Heterochromatin Anomalies and Double-Stranded RNA Accumulation Underlie C9orf72 Poly(PR) Toxicity","volume":"363","author":"Zhang","year":"2019","journal-title":"Science"},{"key":"B78","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/sj.gt.3300938","article-title":"Recombinant Adeno-Associated Virus Purification Using Novel Methods Improves Infectious Titer and Yield","volume":"6","author":"Zolotukhin","year":"1999","journal-title":"Gene Ther."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.863089\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T05:53:11Z","timestamp":1647841991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.863089\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":78,"alternative-id":["10.3389\/fcell.2022.863089"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2022.863089","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]},"article-number":"863089"}}